10 Aug 2023 The potential sleep-promoting effects of a novel probiotic may be related to postbiotic exopolysaccharides (EPS) produced by...

31 July 2023 | By En-Chia Tsai With the theme “Embracing Asian Dynamics” of Bio Asia 2023, the Taipei city government invited Bened...

2023 An elite team led by Professor Tsai Ying-Chieh developed Neuralli, a medical-grade probiotic that has been a hot seller in the...

9 March 2023 | By Bened Life We’ve all had a bad night of sleep – anxious thoughts, uncomfortable sleeping position, needing to get up in...

16 Feburary 2023 | By Prof. Ying-Chieh Tsai, Ph.D. Professor Ying-Chieh Tsai, PhD, Chief Founder at Bened Biomedical, discusses the...

18 November 2022 | By Asia Sherman Live and heat-killed Lactobacillus paracasei PS23 – a probiotic strain isolated from the feces of...

2 November 2022 | By Nikki Hancocks Study: Medical food with omega-3, leucine and probiotic an effective sarcopenia treatment A new...

1 November 2022 | by Prof. Ying-Chieh Tsai, Ph.D. The organ with the second largest number of nerve cells besides your brain is your gut....

11 July 2022 | By Prof. Ying-Chieh Tsai, Ph. D. Your intestinal tract is home to the gut microbiome. These trillions of micro-organisms...

Jun 08, 2022 Bened Biomedical Co, LTD., the global leader in psychobiotics with clinical studies, has acquired its US distributor Oryx...

Medical probiotic leader Bened Biomedical Co., Ltd., which develops and markets neuroactive probiotic products, announced a completed...

每集超過100萬人次收看，廣受矽谷新創圈關注與迴響的知名新創募資實境電視節目【Meet the Drapers】即將於五月邁入第五季，本季將邀請9個國家新創團隊爭奪百萬美金的首獎獎金，也是臺灣首次受邀成為競爭國家之一。 益福生醫團隊以精神益生菌堅實的研發基礎和完整國際布局，...

By Danielle Masterson Emerging research suggests mental health and gut biology are intrinsically linked, presenting new opportunities in...

TAIPEI, April 6, 2022 /PRNewswire/ -- Bened Biomedical announced recent approval of the company's probiotic L. plantarum PS128 in...

(台北訊) 以開發精神益生菌技術及產品為核心的益福生醫公司今日宣布完成A輪募資，共獲得超過千萬美元資金挹注，由華美科技創業投資基金(TPTF)以及集富亞洲 (JAFCO Asia)兩間知名投資機構共同領投。益福生醫期許在兩大創投強力支援下，快速放大國際市場規模、於美國推出自...

22-OCT-2021 A new study analyzing the impact of probiotic PS128 on the symptoms of children with Tourette syndrome has concluded that...

益福生醫共同創辦人蔡恩加代表台灣參與今年10月份APEC 數位時代下女性領導力研討會( APEC CONFERENCE ON WOMEN'S LEADERSHIP IN THE DIGITAL ERA: AGILITY, ADAPTABILITY, FLUENCY)...

（台北訊）有台灣帕金森之父之稱的陸清松醫師與益生菌權威蔡英傑教授合作進行一項「植物乳桿菌PS128對帕金森氏病治療的輔助作用」臨床研究，發現服用抗帕金森氏病的藥物時，若搭配精神益生菌PS128，可顯著縮短病人之「無藥效期」、延長藥效時間，並對活動性、生活自理能力及認知能力顯...

26-AUG-2021 A study involving 40 insomniacs has found that daily administration of the probiotic Lactobacillus plantarum PS128 can reduce...

（台北訊）為鼓勵中小企業創新、扶植研究，經濟部中小企業處推動多項新創補助，成果斐然。其中由國立陽明交通大學產學講座教授蔡英傑領軍的益福生醫研究團隊攜手國內醫學中心精神醫學部身心科醫師，首度推進腸腦軸線精神益生菌研究，將植物乳桿菌PS128應用至人體臨床研究，得到精神益生菌可...